APP and Alzheimer disease: To analyze possible cell-dependent actions of these receptors in AD-like pathology, we crossed either GFAP IR KO or GFAP IGF-IR KO mice with APP/PS1 mice to obtain compound mutants and determined the impact of these receptors in memory loss associated to AD pathology seen in this mouse model.